Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding Epidemic

Hemoglobin
Hassan M MoukhadderAli T Taher

Abstract

The incidence of hepatocellular carcinoma (HCC) in patients with thalassemia is increasing, the two well recognized HCC risk factors in thalassemia being iron overload and chronic hepatitis C. The carcinogenicity of iron is related to its induction of oxidative damage, whereas chronic hepatitis leads to necroinflammation that can accelerate progression to HCC. We hereby report the case of a non transfused, hepatitis C-negative, β-thalassemia intermedia (β-TI) patient from our practice who had evidence of significant iron overload, suggesting the importance of increased iron burden as a HCC risk factor in this patient population. As such, screening thalassemia patients using magnetic resonance imaging (MRI)-based liver iron concentration (LIC) measurement and liver ultrasound is strongly recommended for early detection of iron overload and HCC, respectively. Data appears to be lacking on HCC treatment outcomes in patients who have thalassemia, but an approach tailored to each patient's comorbidities is key to treatment success. The prognosis of these patients can be improved by multicenter studies investigating novel HCC therapeutic targets in the thalassemia realm.

References

Jan 1, 1986·Medical and Pediatric Oncology·C Borgna-PignattiF Avato
Aug 3, 2000·The New England Journal of Medicine·E AngelucciG Lucarelli
Dec 17, 2003·British Journal of Haematology·Caterina Borgna-PignattiMaria Grazia Bisconte
Oct 28, 2004·Gastroenterology·Kris V Kowdley
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Jul 17, 2009·British Journal of Haematology·Ali TaherMaria D Cappellini
Aug 18, 2010·Annals of the New York Academy of Sciences·Elizabeta Nemeth
Dec 17, 2010·World Journal of Hepatology·Andrea Mancuso
Jun 28, 2013·World Journal of Hepatology·Andrea Mancuso
Jul 6, 2014·British Journal of Haematology·Caterina Borgna-PignattiStefano Volpato

❮ Previous
Next ❯

Citations

Aug 5, 2020·BMC Gastroenterology·Alessandra MangiaEugenio Caturelli
Dec 20, 2018·International Journal of Molecular Sciences·Antoine FinianosAli Taher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.